About
NephroDI Therapeutics is a pharmaceutical company developing an oral drug to treat Nephrogenic Diabetes Insipidus (NDI), a rare genetic kidney concentration disorder affecting children.
Explore NephroDI Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.